glp 1 agonist vs sglt2 inhibitor View of Diabetes medications with cardiovascular protection after HARMONY Outcomes and DECLARE-TIMI 58: could metformin, pioglitazone, inhibitors and long-acting GLP-1 receptor agonists complement each other to save lives by different mechanisms? Kidney and Cardiovascular Effectiveness of
Description
Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease

Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients

Glucagon Samols and Marks soon turned their attention to the regulatory effects of glucagon, a polypeptide hormone

Journal of Translational Medicine
